Beam Therapeutics (BEAM) news
Recent news
Banca Mediolanum: BofA global research raises price objective to EUR 25.5 from EUR 24.5
Bank of America’s global research team has raised its price objective for Banca Mediolanum (BMEDM) to EUR 25.5 from EUR 24.5, reflecting improved expectations for the Italian financial services group. The adjustment follows strong performance in 2025, during which Banca Mediolanum reported a record…
AInvest Wire · 1d agoCEAT 2Q other income 50M rupees, +25% y/y
AInvest Wire · 2d agoCEAT 2Q rev. 47.6B rupees, est. 46.49B rupees
AInvest Wire · 2d agoCEAT 2Q net income 1.12B rupees, -40% y/y
AInvest Wire · 2d agoBEM holder sells 200M shrs at 6.5% discount: Terms
Beam Therapeutics (BEM) has announced the pricing of a public offering, with a shareholder selling 200 million shares at a 6.5% discount to the current market price. The terms of the offering have been disclosed, though use of proceeds or pricing mechanism were not included in the provided…
AInvest Wire · Sep 24, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.